These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
62 related items for PubMed ID: 1721370
1. Development of renal dysfunction and renal histological lesions in two patients treated with FK 506 for acute rejection following liver transplantation. Fries D, Rucay P, Samuel D, Hiesse C, Meduri G, Callard P, Fredj G, Bismuth H. Transplant Proc; 1991 Dec; 23(6):3099-100. PubMed ID: 1721370 [No Abstract] [Full Text] [Related]
2. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR. Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [Abstract] [Full Text] [Related]
9. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P. Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635 [Abstract] [Full Text] [Related]
10. Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. Porayko MK, Textor SC, Krom RA, Hay JE, Gores GJ, Wahlstrom HE, Sanchez-Urdazpal L, Richards T, Crotty P, Beaver S. Transplant Proc; 1993 Feb; 25(1 Pt 1):665-8. PubMed ID: 7679835 [No Abstract] [Full Text] [Related]
11. Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Shapiro R, Jordan ML, Scantlebury VP, Fung JJ, Jensen C, Vivas C, McCauley J, Irish WD, Mitchell S, Demetris AJ. Transplant Proc; 1993 Feb; 25(1 Pt 1):669-72. PubMed ID: 7679836 [Abstract] [Full Text] [Related]
16. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J. Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828 [No Abstract] [Full Text] [Related]